Process validation is one of the requirements that distinguishes medical device manufacturing from general industrial production, and adhesive bonding is a process that typically requires validation under ISO 13485-compliant quality systems. A bonded joint — unlike a drilled hole or a machined dimension — cannot be fully verified by inspection of the finished product. The interior of the bond cannot be seen, its strength cannot be measured without destructive testing, and its properties depend on dozens of process variables: surface preparation, mixing ratio, pot life compliance, bondline thickness, cure temperature, and cure time. Because the output quality cannot be fully verified after the fact, the process must be validated — demonstrated prospectively, under controlled conditions, to consistently produce output meeting requirements.
What Process Validation Means for Adhesive Bonding
Validation of a special process — and adhesive bonding is classified as a special process in ISO 13485 because its output cannot be fully verified by inspection — requires establishing that the process, when performed within defined parameters, consistently produces bonds that meet the design requirements.
The validation protocol for an adhesive bonding process defines: the process parameters that must be controlled, the range within which each parameter can vary and still produce acceptable output, the sampling plan for characterizing output quality, the acceptance criteria for each measured attribute, and the number of runs required to demonstrate consistency.
The validation framework used in most medical device quality systems is installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ). IQ documents that the equipment used in the process (dispensers, ovens, scales, fixtures) is installed correctly and meets its specifications. OQ demonstrates that the process, when run at the specified parameters, produces acceptable output across the specified operating range. PQ demonstrates that the process, as run in the production environment by production personnel with production materials and equipment, consistently produces acceptable output over a statistically sufficient number of runs.
Defining the Critical Process Parameters
For an epoxy adhesive bonding process, the critical process parameters (CPPs) — those whose variation within the specified range affects output quality — typically include:
Mixing ratio for two-component systems: Deviation from the specified ratio changes stoichiometry, producing under-cured adhesive with lower Tg, reduced strength, and altered biocompatibility chemistry. The mixing ratio tolerance must be specified and demonstrated to be within the range that produces acceptable output.
Surface preparation: Cleaning method (solvent type, application method), abrasion method and tooling, time between preparation and bonding, and environmental conditions (temperature, humidity) all affect adhesion. The preparation procedure must be specified to the level that it can be reproduced consistently in production.
Bondline thickness: Determines mechanical performance (as discussed in the design specification), and must be controlled within the tolerance established in the design. For applications with spacers, the spacer size and placement are CPPs; for applications without spacers, the application volume and assembly force are CPPs.
Cure temperature and time: The oven setpoint, the ramp rate, the hold time at cure temperature, and the cool-down procedure all affect final Tg and degree of cure. Temperature uniformity across the oven work zone must be documented by thermocouple mapping.
Environmental conditions during assembly: Humidity affects the cure rate and open time of some adhesive systems, and moisture on substrate surfaces reduces adhesion. Defining the acceptable temperature and humidity range for the bonding operation and monitoring it in production is part of process control.
For process parameter selection and validation protocol development for specific Incure adhesive systems, Email Us — Incure can provide technical support for validation protocol writing and CPP identification.
Establishing the Acceptance Criteria
Acceptance criteria for the validated bonding process must be derived from the device design specification, not from the adhesive supplier’s data sheet. The supplier data sheet provides typical properties; the design specification defines the minimum performance required for the device to function safely and as intended.
Lap shear strength is the most common mechanical acceptance criterion for structural adhesive bonds. The minimum required lap shear strength at the design temperature is established from the design load, the bond area, and the required safety factor. A minimum lap shear requirement of 10 MPa, for example, means that every production bond must be capable of withstanding 10 MPa before failure — individual samples at or below this value are non-conforming.
Because destructive lap shear testing cannot be performed on every production assembly, a sampling plan must be established. Coupon specimens prepared alongside production assemblies (witness specimens) using the same materials, the same surfaces, the same process, and the same cure provide a destructive test population that is statistically representative of the production bonds. The sampling frequency, number of specimens per sample, and acceptance criteria for the coupon tests are defined in the validation protocol.
Non-destructive assessment criteria — visual inspection of adhesive fill and squeeze-out, adhesive pot life monitoring (if applicable), oven temperature chart review — provide 100 percent inspection evidence for each production unit that the process was in control without destructive testing of every assembly.
PQ Execution and Lot Release Criteria
PQ runs — typically three consecutive production lots produced under normal production conditions — demonstrate that the validated process produces consistent output in the actual manufacturing environment. Each run uses the production mixing equipment, production oven, production personnel, and production adhesive lots, reproducing the full production environment.
For each PQ run, the defined acceptance criteria are applied to both the witness specimen results and the production process monitoring records. Statistical evaluation of the witness specimen results across the three runs establishes process capability — the Cpk value that quantifies how much margin exists between the process distribution and the acceptance criterion.
Post-validation lot release procedure: for each production lot following successful PQ, the records demonstrating that all CPPs were within their validated ranges, combined with witness specimen test results meeting acceptance criteria, constitute the batch record evidence that the lot was produced in the validated state. Any deviation from validated parameters triggers an investigation and prevents lot release until the impact of the deviation is assessed.
Design Change Control After Validation
Any change to the validated process — different adhesive lot from a new supplier manufacturing site, different surface preparation solvent, different oven, different fixture — requires assessment of whether the change could affect the validated output. Changes judged significant require revalidation before the changed process is used in production. Documentation of this change control process — what was changed, what assessment was done, whether revalidation was performed — is part of the post-validation process maintenance record.
Contact Our Team to discuss process validation protocol development, CPP identification, acceptance criteria derivation, and validation execution support for epoxy adhesive bonding processes in ISO 13485-compliant medical device manufacturing.
Visit www.incurelab.com for more information.